Moreover, the metabolites of bile acids and sphingolipids can further activate the MAPK/mTOR pathway, establishing a self-feeding pattern that reinforces the malignant biological behavior of HCC. The gene discussed is MTOR; the disease is hepatocellular carcinoma.